Skip to content
value.today

AbbVie Inc. vs Alimera Sciences

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • AbbVie Inc. is the larger company by market value: $514.0 B against $209 M for Alimera Sciences, 2459 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for Alimera Sciences). Alimera Sciences's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • AbbVie Inc. had more revenue: $61.2 B in the year to December 2025 against $81 M for Alimera Sciences in the year to December 2023.
  • AbbVie Inc. made a net profit of $4.2 B, while Alimera Sciences made a net loss of $20 M.
  • AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -24.9% for Alimera Sciences.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01222433654862020202120222023202420252026AbbVie Inc. 390Alimera Sciences 486

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$15B$31B$46B$61B20152016201720182019202020212022202320242025AbbVie Inc. $61BAlimera Sciences $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbVie Inc.
ABBV · #26 in the world
Alimera Sciences
ALIM
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded20132003
Size
Market cap$514.0 B$209 M*
Revenue$61.2 B$81 M
Net income$4.2 B▲ best$-20 M
Employees57,000—
Valuation
P/E ratio49.7×—
Price to sales7.8×—
Free cash flow yield3.5%—
Profitability
Gross margin70.2%—
Operating margin24.6%—
Net margin6.9%—
Return on invested capital16.0%—
Growth
Revenue growth8.6%—
Revenue growth, 3 years a year1.8%—
Earnings per share growth-1.3%—
Financial strength
Interest cover5.2×—
Cash
Free cash flow margin29.1%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.5%—
Strength scores
Piotroski F-score8 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, AbbVie Inc. or Alimera Sciences?

AbbVie Inc. is the larger company by market value: $514.0 B against $209 M for Alimera Sciences, 2459 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for Alimera Sciences). Alimera Sciences's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, AbbVie Inc. or Alimera Sciences?

AbbVie Inc. had more revenue: $61.2 B in the year to December 2025 against $81 M for Alimera Sciences in the year to December 2023. AbbVie Inc. made a net profit of $4.2 B, while Alimera Sciences made a net loss of $20 M.

Which is more profitable, AbbVie Inc. or Alimera Sciences?

AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -24.9% for Alimera Sciences.

Sources#

Every figure on this page comes from these, with the date shown next to it.